M H J van Oers
Overview
Explore the profile of M H J van Oers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
669
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
de Heer K, Silbermann M, Koene H, Biemond B, Muller H, van Oers M
Ned Tijdschr Geneeskd
. 2007 Sep;
151(32):1770-6.
PMID: 17822247
Erythrocytosis is a phenomenon with life-threatening complications and a broad differential diagnosis. Erythrocytosis is usually secondary to a cardiopulmonary condition leading to a low arterial oxygen tension. A probable diagnosis...
22.
Hallaert D, Spijker R, Jak M, Derks I, Alves N, Wensveen F, et al.
Cell Death Differ
. 2007 Aug;
14(11):1958-67.
PMID: 17703234
Seliciclib (R-roscovitine) is a cyclin-dependent kinase inhibitor in clinical development. It triggers apoptosis by inhibiting de novo transcription of the short-lived Mcl-1 protein, but it is unknown how this leads...
23.
Bilgin Y, van de Watering L, Eijsman L, Versteegh M, van Oers M, Brand A
Transfus Med
. 2007 Aug;
17(4):304-11.
PMID: 17680957
In two randomized trials in cardiac surgery we observed that leukoreduced allogeneic red blood cell (RBC) transfusions (LR) compared with standard buffy-coat-depleted RBC transfusions (BCD) resulted in lower rates of...
24.
van de Donk N, Kroger N, Hegenbart U, Corradini P, San Miguel J, Goldschmidt H, et al.
Bone Marrow Transplant
. 2006 Jun;
37(12):1135-41.
PMID: 16757975
In this retrospective study, we evaluated donor lymphocyte infusions given for relapsed (n=48) or persistent (n=15) myeloma following non-myeloablative allogeneic stem cell transplantation (Allo-SCT). Twenty-four of 63 patients (38.1%) responded:...
25.
Mous R, Savage P, Remmerswaal E, van Lier R, Eldering E, van Oers M
Leukemia
. 2006 Mar;
20(6):1096-102.
PMID: 16557240
B-cell chronic lymphocytic leukaemia (B-CLL) is a slowly progressing malignancy of CD5(+) B cells, for which at present no curative treatment is available. In our current study, we apply a...
26.
Van Hulst M, Bilgin Y, van de Watering L, de Vries R, van Oers M, Brand A, et al.
Transfus Med
. 2005 Jun;
15(3):209-17.
PMID: 15943705
Cost-effectiveness of leucodepleted erythrocytes (LD) over buffy-coat-depleted packed cells (PC) is estimated from the primary dataset of a recently reported randomized clinical trial involving valve surgery (+/-CABG) patients. Data on...
27.
van Imhoff G, van der Holt B, MacKenzie M, Ossenkoppele G, Wijermans P, Kramer M, et al.
Leukemia
. 2005 Apr;
19(6):945-52.
PMID: 15800666
The feasibility and efficacy of up-front high-dose sequential chemotherapy followed by autologous stem cell transplantation (ASCT) in previously untreated adults (median age 33 years; range 15-64) with Burkitt lymphoma (BL),...
28.
Mackus W, Kater A, Grummels A, Evers L, Hooijbrink B, Kramer M, et al.
Leukemia
. 2005 Jan;
19(3):427-34.
PMID: 15674362
We investigated the apoptosis gene expression profile of chronic lymphocytic leukemia (CLL) cells in relation to (1) normal peripheral and tonsillar B-cell subsets, (2) IgV(H) mutation status, and (3) effects...
29.
Bilgin Y, van de Watering L, Eijsman L, Versteegh M, Brand R, van Oers M, et al.
Circulation
. 2004 May;
109(22):2755-60.
PMID: 15148271
Background: Leukocytes in allogeneic blood transfusions are believed to be the cause of immunomodulatory events. A few trials on leukocyte removal from transfusions in cardiac surgery have been conducted, and...
30.
Doorduijn J, van der Holt B, van Imhoff G, van der Hem K, Kramer M, van Oers M, et al.
J Clin Oncol
. 2003 Aug;
21(16):3041-50.
PMID: 12915593
Purpose: To investigate whether the relative dose-intensity of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy could be improved by prophylactic administration of granulocyte colony-stimulating factor (G-CSF) in elderly patients with...